Granahan Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-22,490
| Closed | -$1.37M | – | 197 |
|
|
2021
Q2 | $1.37M | Buy |
22,490
+7,012
| +45% | +$426K | 0.03% | 185 |
|
|
2021
Q1 | $1.09M | Sell |
15,478
-214,533
| -93% | -$15M | 0.02% | 181 |
|
|
2020
Q4 | $13.8M | Sell |
230,011
-16,719
| -7% | -$1M | 0.31% | 74 |
|
|
2020
Q3 | $14.8M | Sell |
246,730
-22,933
| -9% | -$1.38M | 0.5% | 57 |
|
|
2020
Q2 | $14.1M | Buy |
269,663
+56,650
| +27% | +$2.97M | 0.51% | 57 |
|
|
2020
Q1 | $7.14M | Buy |
213,013
+43,722
| +26% | +$1.47M | 0.38% | 71 |
|
|
2019
Q4 | $7.67M | Buy |
+169,291
| New | +$7.67M | 0.35% | 75 |
|
|
2019
Q1 | – | Sell |
-133,693
| Closed | -$5.75M | – | 200 |
|
|
2018
Q4 | $5.75M | Sell |
133,693
-24,343
| -15% | -$1.05M | 0.41% | 73 |
|
|
2018
Q3 | $7.77M | Sell |
158,036
-30,050
| -16% | -$1.48M | 0.42% | 75 |
|
|
2018
Q2 | $6.03M | Buy |
188,086
+20,617
| +12% | +$661K | 0.36% | 86 |
|
|
2018
Q1 | $5.22M | Sell |
167,469
-4,683
| -3% | -$146K | 0.38% | 89 |
|
|
2017
Q4 | $7.86M | Buy |
172,152
+3,688
| +2% | +$168K | 0.62% | 56 |
|
|
2017
Q3 | $6.33M | Buy |
168,464
+27,609
| +20% | +$1.04M | 0.53% | 73 |
|
|
2017
Q2 | $6.72M | Buy |
140,855
+8,190
| +6% | +$391K | 0.62% | 54 |
|
|
2017
Q1 | $6.05M | Sell |
132,665
-503,815
| -79% | -$23M | 0.61% | 59 |
|
|
2016
Q4 | $20.6M | Sell |
636,480
-34,130
| -5% | -$1.1M | 0.71% | 53 |
|
|
2016
Q3 | $22.9M | Buy |
670,610
+462,110
| +222% | +$15.8M | 0.75% | 41 |
|
|
2016
Q2 | $7.03M | Buy |
208,500
+49,500
| +31% | +$1.67M | 0.26% | 131 |
|
|
2016
Q1 | $8.42M | Buy |
159,000
+68,300
| +75% | +$3.62M | 0.31% | 111 |
|
|
2015
Q4 | $6.97M | Sell |
90,700
-91,100
| -50% | -$7M | 0.24% | 130 |
|
|
2015
Q3 | $7.47M | Buy |
+181,800
| New | +$7.47M | 0.23% | 140 |
|